TY - JOUR
T1 - Significance of estimated glomerular filtration rate in predicting brain or heart attacks in obese and non-obese populations
AU - Sato, Yuji
AU - Fujimoto, Shouichi
AU - Konta, Tsuneo
AU - Iseki, Kunitoshi
AU - Moriyama, Toshiki
AU - Yamagata, Kunihiro
AU - Tsuruya, Kazuhiko
AU - Kimura, Kenjiro
AU - Narita, Ichiei
AU - Kondo, Masahide
AU - Asahi, Koichi
AU - Kurahashi, Issei
AU - Ohashi, Yasuo
AU - Watanabe, Tsuyoshi
N1 - Funding Information:
This work was supported by Health and Labour Sciences Research Grants for “Research on the Positioning of Chronic Kidney Disease in Specific Health Check and Guidance in Japan” (20230601) from the Ministry of Health, Labour and Welfare of Japan.
Publisher Copyright:
© 2014, Japanese Society of Nephrology.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Background: The Japanese Specific Health Checkup mainly focuses on metabolic syndrome for preventing cardiovascular events. Subjects are stratified by measuring waist circumference, body mass index, blood pressure, triglycerides, and fasting plasma glucose. However, estimated glomerular filtration rate (eGFR) is not considered essential. Methods: A longitudinal cohort study assessed the association of eGFR with new-onset brain or heart attacks in a large Japanese nationwide Specific Health Checkup database. A total of 109,349 Japanese subjects (mean age 63.2 years, 39.5 % men) were examined for the events 2 years later. The odds ratios were calculated for new events in the total and subgroup populations divided by BMI < or ≥25 kg/m2, obese and non-obese, respectively. Results: Obese subjects were more often male and had proteinuria (dipstick test ≥1+), lower eGFR, and higher systolic and diastolic BP, fasting plasma glucose, hemoglobin A1c, and triglycerides (TG). Rates of new-onset brain or heart attacks were 3.1 and 4.0 % in the groups of non-obese and obese subjects, respectively. In the total population, eGFR as well as higher BMI (≥25 kg/m2), higher BP (high-normal hypertension or greater), higher TG (≥150 mg/dl), and proteinuria were significant risk factors for developing brain or heart attacks. The eGFR was significant in non-obese subjects, but not in the obese. Conclusion: As the ultimate aim of ‘Specific Health Checkup’ is to prevent cardiovascular events, our study suggests that eGFR should be evaluated in non-obese subjects.
AB - Background: The Japanese Specific Health Checkup mainly focuses on metabolic syndrome for preventing cardiovascular events. Subjects are stratified by measuring waist circumference, body mass index, blood pressure, triglycerides, and fasting plasma glucose. However, estimated glomerular filtration rate (eGFR) is not considered essential. Methods: A longitudinal cohort study assessed the association of eGFR with new-onset brain or heart attacks in a large Japanese nationwide Specific Health Checkup database. A total of 109,349 Japanese subjects (mean age 63.2 years, 39.5 % men) were examined for the events 2 years later. The odds ratios were calculated for new events in the total and subgroup populations divided by BMI < or ≥25 kg/m2, obese and non-obese, respectively. Results: Obese subjects were more often male and had proteinuria (dipstick test ≥1+), lower eGFR, and higher systolic and diastolic BP, fasting plasma glucose, hemoglobin A1c, and triglycerides (TG). Rates of new-onset brain or heart attacks were 3.1 and 4.0 % in the groups of non-obese and obese subjects, respectively. In the total population, eGFR as well as higher BMI (≥25 kg/m2), higher BP (high-normal hypertension or greater), higher TG (≥150 mg/dl), and proteinuria were significant risk factors for developing brain or heart attacks. The eGFR was significant in non-obese subjects, but not in the obese. Conclusion: As the ultimate aim of ‘Specific Health Checkup’ is to prevent cardiovascular events, our study suggests that eGFR should be evaluated in non-obese subjects.
UR - http://www.scopus.com/inward/record.url?scp=84944168788&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84944168788&partnerID=8YFLogxK
U2 - 10.1007/s10157-014-1062-2
DO - 10.1007/s10157-014-1062-2
M3 - Article
C2 - 25433815
AN - SCOPUS:84944168788
SN - 1342-1751
VL - 19
SP - 790
EP - 796
JO - Clinical and Experimental Nephrology
JF - Clinical and Experimental Nephrology
IS - 5
ER -